Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Stomatitis 1Neoplasms 1Melanoma 1Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Methylene Blue × Clear all
NCT03469284 2023-04-25

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

M.D. Anderson Cancer Center

Phase 2 Completed
69 enrolled 11 charts

Neoplasms, Stomatitis

NCT02057393 2017-07-06

SPY-SN

Milton S. Hershey Medical Center

Phase NA Completed
89 enrolled 3 charts
Dermatologic

Melanoma

NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed
62 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡